Yakult Honsha Co Ltd
2267: XTKS (JPN)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|gt | LOCK|!@Hs | LOCK|?w#W^SC |
Signs of Recovery in Asia Offsets Weaker Domestic Performance
Business Strategy and Outlook
Research and development in probiotics, primarily in beverage products and pharmaceuticals, has laid the foundation for Yakult. Its flagship products are probiotic drinks marketed under the namesake brand in 40 countries across four continents, making up an estimated 80% of group sales and 90% of profits. Expanding the international footprint and enhancing domestic profitability through premiumization are the two pillars of Yakult’s growth strategy under its new midterm plan to 2030.
